We have examined ␣12␥2L GABA A receptor modulation by the endogenous steroids allopregnanolone (3␣5␣P), pregnenolone sulfate, and -estradiol in the absence and presence of ethanol. Coapplication of 0.1 to 1% (17-170 mM) ethanol influenced receptor modulation by 3␣5␣P but not that by pregnenolone sulfate or -estradiol. One of the three kinetic effects evident in channel potentiation by 3␣5␣P, prolongation of the longest-lived open time component (OT3), was affected by ethanol with the midpoint of its dose-response curve moved to lower steroid concentrations by 2 orders of magnitude without significantly affecting the maximal effect. Manipulations designed to affect the ability of 3␣5␣P to prolong OT3 also affected OT3 prolongation in the presence of ethanol. A mutation to the ␥2 subunit, which reduces the ability of 3␣5␣P to prolong OT3, also reduces the interaction between ethanol and 3␣5␣P. And the presence of the competitive steroid antagonist (3␣,5␣)-17-phenylandrost-16-en-3-ol (17-PA) diminishes the positive interaction between ethanol and 3␣5␣P on the GABA A receptor. Together, the findings suggest that steroid interactions with the classic steroid binding site underlie the effect seen in the presence of ethanol, and that ethanol acts by increasing the affinity of 3␣5␣P for the site. Tadpole behavioral assays showed that the presence of 3␣5␣P at a concentration ineffective at causing changes in tadpole behavior shifted the ethanol dose-response curve for loss of righting reflex to lower concentrations and that this effect was neutralized by coapplication of 17-PA with 3␣5␣P.From a pharmacologist's point of view, the GABA A receptor presents a fascinating case, because the receptor can be modulated by a wide collection of structurally unrelated drugs, most with their own individual binding sites. The GABA A receptor constitutes the dominant fast inhibitory force in the central nervous system. It is unsurprising that compounds that potentiate receptor function have anesthetic or anticonvulsant properties, and conversely, that inhibitors of the GABA A receptor can act as cognitive enhancers or elicit seizures. The clinical implications have undoubtedly fueled the interest in receptor function resulting in rapid progress in recent years in the identification of interaction sites and mechanisms of action for the modulators of the GABA A receptor.Neuroactive steroids are among the best-described GABA A receptor modulators. The ability of steroids to modify GABA A receptor activity has been known since the 1980s (Harrison and Simmonds, 1984); since then, significant progress has been made in terms of describing the kinetic and structural mechanisms (e.g., Puia et al., 1990;Akk et al., 2004; Hosie et al., 2005) as well as understanding the physiological significance of steroid modulation (for reviews see, Baulieu, 1998;Belelli and Lambert, 2005). Exposure to most steroids has a major effect on gating or desensitization of the receptorchannel. Potentiating steroids (e.g., 3␣5␣P) enhance the channel open...